Company OPKO Health, Inc.

Equities

OPK

US68375N1037

Healthcare Facilities & Services

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
0.8655 USD -3.27% Intraday chart for OPKO Health, Inc. -8.11% -42.68%

Business Summary

OPKO Health, Inc. is a healthcare company. The Company's segments include diagnostics and pharmaceuticals. The diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. The pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates laboratory divisions, such as BioReference Health, GenPath and GenPath. Its Pharmaceutical Business has one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including pharmaceutical compounds, Oxyntomodulin, Biologics, Factor VIIa-CTP and others. It also owns an active pharmaceutical ingredients manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Number of employees: 3,930

Sales per Business

USD in Million2022Weight2023Weight Delta
Diagnostics
59.7 %
756 75.2 % 515 59.7 % -31.81%
Pharmaceutical
40.3 %
249 24.8 % 348 40.3 % +40.09%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
69.2 %
783 78.0 % 598 69.2 % -23.67%
Ireland
16.4 %
117 11.7 % 141 16.4 % +20.69%
Chile
7.9 %
62 6.2 % 68 7.9 % +10.39%
Spain
2.7 %
22 2.2 % 24 2.7 % +4.63%
Mexico
2.3 %
15 1.4 % 20 2.3 % +38.98%
Israel
1.1 %
4 0.4 % 10 1.1 % +153.26%
Other
0.3 %
1 0.1 % 2 0.3 % +160.25%

Managers

Managers TitleAgeSince
Chief Executive Officer 87 07-03-26
Director of Finance/CFO 46 07-02-28
President 71 22-05-08
Chief Tech/Sci/R&D Officer 72 22-04-30
Chief Tech/Sci/R&D Officer 77 07-01-31
Chief Administrative Officer 63 07-01-31
Director/Board Member 70 22-05-08
General Counsel - -
Corporate Officer/Principal - 14-04-08

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 87 07-03-26
Director/Board Member 77 20-12-17
Director/Board Member 68 07-12-31
Chief Administrative Officer 63 07-01-31
Chief Tech/Sci/R&D Officer 77 07-01-31
Director/Board Member 89 03-11-30
Director/Board Member 82 17-02-08
Director/Board Member 52 22-05-08
President 71 22-05-08
Director/Board Member 70 22-05-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 705,646,759 414,144,720 ( 58.69 %) 8,655,082 ( 1.227 %) 58.69 %

Shareholders

NameEquities%Valuation
243,664,353 34.96 % 244 M $
40,745,228 5.846 % 41 M $
Vanguard Fiduciary Trust Co.
5.703 %
39,751,293 5.703 % 40 M $
The Vanguard Group, Inc.
5.703 %
39,751,293 5.703 % 40 M $
BlackRock Advisors LLC
4.958 %
34,559,815 4.958 % 35 M $
Jane Hsaio
4.753 %
33,127,284 4.753 % 33 M $
Gary Nabel
2.945 %
20,526,980 2.945 % 21 M $
19,912,459 2.857 % 20 M $
Geode Capital Management LLC
1.394 %
9,719,368 1.394 % 10 M $
KSM Mutual Funds Ltd.
1.363 %
9,499,679 1.363 % 9 M $

Holdings

NameEquities%Valuation
3,558,601 13.66% 29,002,598 $

Company contact information

OPKO Health, Inc.

4400 Biscayne Boulevard

33137, Miami

+305 575 4100

http://www.opko.com
address OPKO Health, Inc.(OPK)